Nrc Health (NRC) Cash & Equivalents (2010 - 2026)

Nrc Health has disclosed Cash & Equivalents across 17 years of filings, most recently posting $3.3 million for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 36.92% year-over-year to $3.3 million; the TTM figure through Jun 2026 stood at $3.3 million (down 36.92% YoY), while the FY2025 annual figure was $4.1 million, down 2.22% from the prior year.
• Cash & Equivalents came in at $3.3 million for Q2 2026 at Nrc Health, up from $2.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $47.3 million in Q1 2022 to a low of $485000.0 in Q2 2024.
• Average Cash & Equivalents over 5 years is $12.2 million, with a median of $4.2 million recorded in 2024.
• Year-over-year, Cash & Equivalents plunged 97.84% in 2024 and jumped 987.42% in 2025.
• Over 5 years, Cash & Equivalents stood at $25.0 million in 2022, then slumped by 73.42% to $6.7 million in 2023, then plunged by 36.37% to $4.2 million in 2024, then slipped by 2.22% to $4.1 million in 2025, then declined by 19.62% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $3.3 million in Q2 2026, $2.5 million in Q1 2026, and $4.1 million in Q4 2025.